TX Austin의 암 (전체) 임상 시험
암 (전체) 관련 연구 21개가 Austin 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
피험자 모집 중3상
- Texas Oncology, Austin
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
피험자 모집 중3상
- Dell Seton Medical Center at The University of Texas, Austin
- University of Texas at Austin, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
피험자 모집 중1상
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
피험자 모집 중관찰 연구
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
피험자 모집 중2상
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
피험자 모집 중1/2상
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
피험자 모집 중2상
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
피험자 모집 중2/3상
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
피험자 모집 중2상
- Texas Oncology - Austin Central, Austin
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
피험자 모집 중2상
- Texas Oncology-Austin North /ID# 279958, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
피험자 모집 중1상
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
피험자 모집 중관찰 연구건강한 지원자 환영
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
피험자 모집 중1/2상
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
피험자 모집 중1/2상
- NEXT Oncology Austin, Austin
다른 도시의 암 (전체) 시험
- Houston, TX연구 122개
- New York City, NY연구 110개
- Boston, MA연구 86개
- Los Angeles, CA연구 73개
- Nashville, TN연구 65개
- Washington, DC연구 60개
- Philadelphia, PA연구 60개
- Durham, NC연구 59개
- Chicago, IL연구 52개
- Seattle, WA연구 50개
- Atlanta, GA연구 50개
- Arlington, VA연구 48개
Austin의 다른 연구
- 비소세포폐암연구 30개
- 비만연구 20개
- 대장직장암연구 19개
- 전이성 암연구 19개
- 심부전연구 18개
- 과체중연구 18개
- 유방암연구 18개
- 난소암연구 17개
- 자궁내막암연구 16개
- 전립선암연구 15개
- 우울증연구 14개
- 삼중음성 유방암연구 13개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.